{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:17:56Z","timestamp":1761718676397,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministry of Science and Higher Education","doi-asserted-by":"publisher","award":["MN \u2013 01-0085\/08\/"],"award-info":[{"award-number":["MN \u2013 01-0085\/08\/"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejps.2018.05.015","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T12:13:31Z","timestamp":1526472811000},"page":"95-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Ocular irritation and cyclosporine A distribution in the eye tissues after administration of Solid Lipid Microparticles in the rabbit model"],"prefix":"10.1016","volume":"121","author":[{"given":"Eliza","family":"Wolska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Sznitowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliusz","family":"Chor\u0105\u017cewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliwia","family":"Szerkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Radwa\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142 J.","family":"Markuszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Kaliszan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystyna","family":"Raczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.05.015_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/bmb\/ldv002","article-title":"Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals","volume":"113","author":"Abdelkader","year":"2015","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.ejps.2018.05.015_bb0010","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1517\/17425247.2014.935335","article-title":"Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals","volume":"11","author":"Aburahma","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2018.05.015_bb0015","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.addr.2007.04.007","article-title":"Solid lipid nanoparticles as a drug delivery system for peptides and proteins","volume":"59","author":"Almeida","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2018.05.015_bb0020","series-title":"ICCVAM Summary Review Document: The Low Volume Eye Test","first-page":"1","author":"Appendix B","year":"2010"},{"key":"10.1016\/j.ejps.2018.05.015_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/02652040902846883","article-title":"Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery","volume":"27","author":"Ba\u015faran","year":"2010","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2018.05.015_bb0030","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0022-2275(20)42013-9","article-title":"Lipoprotein lipase in higly vascularized structures of the eye","volume":"37","author":"Casaroli-Marano","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejps.2018.05.015_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.4.3.1","article-title":"Topical, aqueous, clear cyclosporine formulation design for anterior and posterior ocular delivery","volume":"4","author":"Cholkar","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ejps.2018.05.015_bb0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejpb.2013.07.017","article-title":"Solid lipid particles for oral delivery of peptide and protein drugs I - elucidating the release mechanism of lysozyme during lipolysis","volume":"85","author":"Christophersen","year":"2013","journal-title":"Eur. J. Pharm. Bipharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0045","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1007\/s11095-014-1337-z","article-title":"Solid lipid particles for oral delivery of peptide and protein drugs II - the digestion of trilaurin protects desmopressin from proteolytic degradation","volume":"31","author":"Christophersen","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.05.015_bb0050","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3109\/03639045.2014.938656","article-title":"Comparison of cytotoxicity in vitro and irritation in vivo for aqueous and oily solutions of surfactants","volume":"41","author":"Czajkowska-Ko\u015bnik","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0055","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/ICO.0b013e31825e83f4","article-title":"Distribution of cyclosporine A in ocular tissues after topical administration of cyclosporine A cationic emulsions to pigmented rabbits","volume":"32","author":"Daull","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ejps.2018.05.015_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00760-8","article-title":"Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A","volume":"224","author":"De Campos","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2014.02.005","article-title":"Nanotoxicology applied to solid nanoparticles and nanostructured lipid carriers \u2014 a systematic review of in vitro data","volume":"87","author":"Doktorovova","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejpb.2016.08.001","article-title":"Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: current evidence from in vitro and in vivo evaluation","volume":"108","author":"Doktorovova","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2008.08.004","article-title":"Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: In vitro and in vivo results","volume":"365","author":"Gan","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0080","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.msec.2016.05.119","article-title":"Solid lipid nanopaerticles as attractive drug vehicles: composition, properties and therapeutic strategies","volume":"68","author":"Geszke-Moritz","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejps.2018.05.015_bb0085","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2008.07.028","article-title":"Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity","volume":"364","author":"Gokce","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0090","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3109\/02713680903261405","article-title":"Cyclosporine A-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes","volume":"34","author":"G\u00f6k\u00e7e","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejps.2018.05.015_bb0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2016.01.056","article-title":"Reformulating cyclosporine A (CsA): more than just a life cycle management strategy","volume":"225","author":"Guada","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.05.015_bb0100","first-page":"425","article-title":"Solid lipid microparticles: an approach for improving oral bioavailability of aspirin","volume":"10","author":"Gugu","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.05.015_bb0105","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1167\/iovs.05-1373","article-title":"Cyclosporine-loaded microspheres for treatment of uveitis: In vitro characterization and in vivo pharmacokinetic study","volume":"47","author":"He","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2018.05.015_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/jop.2006.22.121","article-title":"Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits","volume":"22","author":"He","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.05.015_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2014.06.017","article-title":"Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A","volume":"472","author":"Hermans","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1517\/17425247.2.1.75","article-title":"Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications","volume":"2","author":"Jaspart","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2018.05.015_bb0125","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.addr.2008.09.002","article-title":"Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery","volume":"60","author":"Jiao","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2018.05.015_bb0130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1600-0420.1999.770217.x","article-title":"Toxicological evaluation of cyclosporine eyedrops","volume":"77","author":"Knagenhjelm","year":"1999","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.ejps.2018.05.015_bb0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0939-6411(03)00138-3","article-title":"Cyclosporine A delivery to the eye: a pharmaceutical challenge","volume":"56","author":"Lallemand","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijpharm.2004.12.015","article-title":"A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics","volume":"295","author":"Lallemand","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0145","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1442-9071.2004.00914.x","article-title":"New vehicle based on a microemulsion for topical ocular administration of dexamethasone","volume":"32","author":"Lig\u00f3rio Fialho","year":"2004","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejps.2018.05.015_bb0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(96)04731-X","article-title":"Biodegradation of solid lipid nanoparticles as a function of lipase incubation time","volume":"144","author":"M\u00fcller","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2014 a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4172\/jbb.1000050","article-title":"Development and characterization of solid-lipid microparticles of highly insoluble drug sirolimus","volume":"3","author":"Nanjwade","year":"2011","journal-title":"J. Bioequivalence Bioavailab."},{"key":"10.1016\/j.ejps.2018.05.015_bb0165","first-page":"48","article-title":"Evaluation of cyclosporine A eye absorption after administration of liposomal or conventional forms in animal model","volume":"1","author":"Nikoofal-Sahlabadi","year":"2013","journal-title":"Nanomed J."},{"key":"10.1016\/j.ejps.2018.05.015_bb0170","series-title":"Interlaboratory Validation of the in vitro eye Irritation Tests for Cosmetic Ingredients. (1) Overview of the Validation Study and Draize Scores for the Evaluation of the tests","first-page":"73","volume":"13","author":"Ohno","year":"1999"},{"key":"10.1016\/j.ejps.2018.05.015_bb0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-5173(98)00404-9","article-title":"Enzymatic degradation of SLN \u2014 effect of surfactant and surfactant mixtures","volume":"180","author":"Olbrich","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0180","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2005.11.038","article-title":"The expulsion of lipophilic drugs from the cores of solid lipid microspheres in diluted suspensions and in concentrates","volume":"310","author":"Pietkiewicz","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0185","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3109\/02713683.2010.508867","article-title":"In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye","volume":"35","author":"Rafie","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejps.2018.05.015_bb0190","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00003226-199007000-00003","article-title":"The collagen shield a new vehicle for delivery of cyclosporin A to the eye","volume":"9","author":"Reidy","year":"1990","journal-title":"Cornea"},{"key":"10.1016\/j.ejps.2018.05.015_bb0195","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejpb.2015.02.019","article-title":"Nanotherapies for the treatment of ocular diseases","volume":"95","author":"Reimondez-Troiti\u00f1o","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2009.07.008","article-title":"Studies on the lipase induced degradation of lipid based drug delivery systems","volume":"140","author":"Schwab","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.05.015_bb0205","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2010.10.008","article-title":"Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution","volume":"402","author":"Shen","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0210","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s003470100535","article-title":"Der modifizierte Heidelberg-Retina-Tomograph HRT","volume":"99","author":"Stave","year":"2002","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.ejps.2018.05.015_bb0215","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/bmc.3132","article-title":"Development and validation of UHPLC method for the determination of cyclosporine A in biological samples","volume":"28","author":"Szerkus","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejps.2018.05.015_bb0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejpb.2016.10.023","article-title":"The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN)","volume":"110","author":"Sznitowska","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0225","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00003088-200544030-00003","article-title":"Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye","volume":"44","author":"Tang-Liu","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2018.05.015_bb0230","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","article-title":"Clinical review: topical ophthalmic use of cyclosporin A","volume":"18","author":"Utine","year":"2010","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0235","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","article-title":"The Draize eye test","volume":"45","author":"Wilhelmus","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejps.2018.05.015_bb0240","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tox.2014.11.003","article-title":"An overview of current techniques for ocular toxicity testing","volume":"327","author":"Wilson","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.ejps.2018.05.015_bb0245","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijpharm.2012.11.009","article-title":"Technology of stable, prolonged-release eye-drops containing cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM)","volume":"441","author":"Wolska","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.015_bb0250","first-page":"3587","article-title":"Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels","volume":"8","author":"Wu","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2018.05.015_bb0255","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2008.04.002","article-title":"Hyaluronic acid coated poly-\u03b5-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea","volume":"87","author":"Yenice","year":"2008","journal-title":"Exp. Eye Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718302343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718302343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:47:37Z","timestamp":1760528857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718302343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":51,"alternative-id":["S0928098718302343"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.05.015","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular irritation and cyclosporine A distribution in the eye tissues after administration of Solid Lipid Microparticles in the rabbit model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}